Your shopping cart is currently empty

BI 689648 is a highly selective inhibitor of aldosterone synthase(CYP11B1 and CYP11B2 with IC50s of 310 and 2.1 nM, respectively).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $985 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,280 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $1,940 | 6-8 weeks | 6-8 weeks | |
| 1 mL x 10 mM (in DMSO) | $272 | 6-8 weeks | 6-8 weeks |
| Description | BI 689648 is a highly selective inhibitor of aldosterone synthase(CYP11B1 and CYP11B2 with IC50s of 310 and 2.1 nM, respectively). |
| Targets&IC50 | CYP11B2:2.1 nM, CYP11B1:310 nM |
| In vitro | In comparison with FADs and LCI699, BI 689648 exhibits remarkable selectivity in vitro, demonstrating an IC50 value of 2.1 nM for CYP11B2 and a selectivity factor of 149 over CYP11B1. Meanwhile, FAD286 presents a comparable IC50 value for CYP11B2 at 2.5 nM, but its higher efficacy against CYP11B1 (94 nM) yields a relatively lower selectivity factor of 38, which is about fourfold lesser than that of BI 689648[1]. |
| In vivo | After oral administration in cyno monkeys, BI 689648 (5 mg/kg) achieves a peak plasma concentration of ~500 nM. BI 689648 minimally impacts 11-DC, but only at very high plasma concentrations (~10 μM)[1]. For BI 689648 (aldosterone EC50 = 2 nM), significant changes in 11-DOC are observed at plasma concentrations >2000 nM or >1000-fold its aldosterone EC50, whereas FAD286 exhibits a window of ~100-fold. |
| Molecular Weight | 298.34 |
| Formula | C16H18N4O2 |
| Cas No. | 1633009-87-6 |
| Smiles | COCc1cncc(c1)-c1cnc2N(CCCc2c1)C(N)=O |
| Relative Density. | 1.260 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 30 mg/mL (100.56 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2 mg/mL (6.7 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.